{
  "ticker": "LTP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963309",
  "id": "02963309",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250630",
  "time": "0832",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250630/pdf/06l7gnlth7dtfh.pdf",
  "summary": "**Regulatory Milestone Announcement Summary:**  \n\n- **Extractables study completed** for SPONTAN\u00ae (intranasal spray for erectile dysfunction); all compounds below ICH safety thresholds.  \nA\n- **Leachables study initiated**, required for FDA 505(b)(2) submission; 24-month duration to support shelf-life data.  \nA\n- **Progresses regulatory pathway** toward FDA New Drug Application (CMC section). No immediate capital or trading impact noted.  \n\n*No material financial/trading data disclosed.*",
  "usage": {
    "prompt_tokens": 1301,
    "completion_tokens": 111,
    "total_tokens": 1412,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-29T22:51:26.369389"
}